tradingkey.logo

Co-Diagnostics Inc

CODX
查看詳細走勢圖
2.360USD
0.0000.00%
收盤 02/06, 16:00美東報價延遲15分鐘
113.62M總市值
虧損本益比TTM

Co-Diagnostics Inc

2.360
0.0000.00%
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

0.00%

5天

0.00%

1月

-60.86%

6月

+856.63%

今年開始到現在

+1299.76%

1年

+243.22%

查看詳細走勢圖

TradingKey Co-Diagnostics Inc股票評分

單位: USD 更新時間: 2026-01-13

操作建議

Co-Diagnostics Inc當前公司基本面數據相對非常健康,最新ESG揭露屬於行業中等水平。增長潛力穩定。當前估值合理,在醫療設備與耗材行業排名120/208位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為37.50。中期看,股價處於上升通道。近一個月,市場表現很強,技術面評分較高,但很強的走勢沒有得到基本面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。

Co-Diagnostics Inc評分

相關信息

行業排名
120 / 208
全市場排名
308 / 4563
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
中性

Co-Diagnostics Inc亮點

亮點風險
Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.
業績增長期
公司處於發展階段,最新年度總收入3.92M美元
利潤高增長
公司淨利潤處於行業前列,最新年度總收入3.92M美元
估值低估
公司最新PE估值-2.42,處於3年歷史低位
機構加倉
最新機構持股375.84K股,環比增加21.57%
詹姆斯·西蒙斯持倉
明星投資者詹姆斯·西蒙斯持倉,最新持倉28.92K股
活躍度增加
近期活躍度增加,過去20天平均換手率10.46

分析師目標

基於 2 分析師
持有
評級
30.000
目標均價
+1171.19%
漲幅空間
數據免責聲明:分析師評級與目標價由LSEG提供,僅供參考,不應當作投資建議

Co-Diagnostics Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

Co-Diagnostics Inc簡介

Co-Diagnostics, Inc. is a molecular diagnostics company, which develops, manufactures and markets diagnostics technologies. The Company’s technologies are utilized for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). The Company also uses its proprietary technology to design specific tests for its Co-Dx PCR platform and to locate genetic markers for use in applications other than infectious disease. Its diagnostics systems enable dependable, low-cost, molecular testing for organisms and genetic diseases by automating or simplifying historically complex procedures in both the development and administration of tests. It is developing a portable diagnostic device and test system designed for point-of-care and at-home use. The system consists of its PCR instrument that it refers to as the Co-Dx PCR Pro instrument, its proprietary diagnostic test cup system and a mobile application to be installed on the user’s mobile device.
公司代碼CODX
公司Co-Diagnostics Inc
CEOEgan (Dwight H)
網址https://codiagnostics.com/
KeyAI